Lineage Cell Therapeutics has found an experienced hearing loss partner to advance a potentially novel transplant for auditory neurons. William Demant Invest, the largest shareholder of Danish hearing ...
Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. AI rarely fails because of bad models alone. More often it fails ...
CEO W. Lehmkuhl began by welcoming new Head of Investor Relations Ki Bin Kim and noted that third quarter performance was slightly ahead of expectations. Lehmkuhl stated that "total revenue increased ...
Fintel on MSN
Barclays downgrades Lineage (LINE)
Fintel reports that on January 13, 2026, Barclays downgraded their outlook for Lineage (NasdaqGS:LINE) from Overweight to ...
Positive RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results Featured at Clinical Trials at the Summit 2025 Entered Collaboration with William Demant Invest to Develop ReSonance™ (ANP1) for ...
We use the following non-GAAP financial measures as supplemental performance measures of our business: segment NOI, FFO, Core FFO, Adjusted FFO, EBITDA, EBITDAre, Adjusted EBITDA, and Adjusted EBITDA ...
Lineage (LINE), the world’s largest cold storage operator, is trading over 50% below recent highs but remains a dominant industry force. LINE is well-positioned for long-term growth and industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback